Corona Remedies Limited IPO
Corona Remedies Limited IPO
Corona Remedies Limited IPO
₹ 14868 / 14 Shares Shares
Minimum Investment
Corona Remedies Limited IPO
Issues Price
₹1008-1062 per equity share
Corona Remedies Limited IPO
Open Date
08 Dec 2025
Close Date
10 Dec 2025
Lot Size
14
Min. Investment
₹ 14868
Issue Price
₹1008-1062
Listing Date
15 Dec 2025
Issues Size
61,71,101 shares(aggregating up to ₹655.37 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
14 Shares
Offered To Public
14 Shares
Corona Remedies Limited IPO
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
Founded In
2004
Managing Director
Dr. Kirtikumar Laxmidas Mehta
Parent Organization
Corona Remedies Limited IPO
Application Details of Corona Remedies Limited IPO.
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.
New fund investing used to be intimidating. KSquare’s support and transparency made it not only easy but enjoyable. I now look forward to NFOs!
KSquare helped me reconnect financially with India. Their NRI services are intuitive, quick, and focused on individual needs. Truly impressed!
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.
Thanks to KSquare’s New Fund Offering alerts, I’ve been able to catch early opportunities that matched my long-term strategy and risk appetite.
KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.
KSquare offers outstanding NFO briefings that help investors understand the market fit. They truly empower clients with knowledge before any commitment.
KSquare’s pension guidance was much needed. Their team helped me select the right NPS tier and gave detailed explanations.
I never explored NFOs until KSquare simplified the process. Their breakdown of fund objectives helped me make confident decisions as a first-time investor.
FAQ's
Frequenlty Asked Question
Are there any charges for managing NPS?
Yes, nominal charges apply for account maintenance and fund management, but they are among the lowest in the industry.
Is NPS a market-linked investment?
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
What documents are needed to invest in an NFO through KSquare?
You’ll need KYC-compliant documents like PAN, Aadhaar, and bank details to invest in NFOs through KSquare.
Are SIPs better than lump sum investments?
SIPs help average out market volatility over time, making them a safer and more consistent choice than lump sum investing.
Is it legal for NRIs to invest in Indian markets via KSquare?
Absolutely. KSquare complies with all SEBI and RBI guidelines, ensuring legal and secure investments for NRIs.
Are mutual funds suitable for short-term goals?
Debt and liquid funds are ideal for short-term goals, while equity funds are better for long-term wealth creation.
How much money do I need to start investing in mutual funds?
You can begin with as little as ₹100, making mutual funds accessible to new and seasoned investors alike.
What if I need money before my SIP goal time?
Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.